中國互動播客平台荔枝赴美上市 集資最多5,330萬美元
中國互動播客平台荔枝(Lizhi)向美國證券及交易委員會提交文件,披露詳細赴美上市計劃。公司計劃發行410萬份美國預託證券,每份介乎11至13美元,最高集資額5,330萬美元。按中位數定價,公司的估值為5.49億美元。文件指,新浪微博及小米(01810.HK)擬在招股期間購入總值3,600萬美元股份。
截至去年9月底止年度,荔枝收入1.52億美元。公司計劃於納斯達克交易所掛牌,料於下周公布上市定價。花旗、海通國際、AMTD Global Markets、Needham & Company及老虎證券為聯合承銷商。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.